Completed
GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma
NCT01245062
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Fort Myers, Florida, United States
- GSK Investigational Site Athens, Georgia, United States
- GSK Investigational Site Marietta, Georgia, United States